“Securing the Series B round enables Miracor to start its early commercialization strategy with (1) enrollment into the RAMSES trials, (2) European reimbursement, and (3) sales activities. We also are very pleased to be supported by AWS and the new investor SHS.” Jon H. Hoem, CEO, Miracor Medical Systems

Click here to read the full press release.